REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 52 filers reported holding REGULUS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $95,000 | -70.2% | 483,951 | 0.0% | 0.00% | – |
| Q2 2018 | $319,000 | -8.1% | 483,951 | 0.0% | 0.00% | – |
| Q1 2018 | $347,000 | -31.0% | 483,951 | 0.0% | 0.00% | – |
| Q4 2017 | $503,000 | -16.7% | 483,951 | 0.0% | 0.00% | – |
| Q3 2017 | $604,000 | +190.4% | 483,951 | +128.8% | 0.00% | – |
| Q2 2017 | $208,000 | -52.5% | 211,540 | -20.4% | 0.00% | – |
| Q1 2017 | $438,000 | -24.2% | 265,774 | +3.4% | 0.00% | – |
| Q4 2016 | $578,000 | -29.9% | 257,045 | +2.9% | 0.00% | – |
| Q3 2016 | $824,000 | +43.3% | 249,768 | +25.5% | 0.00% | – |
| Q2 2016 | $575,000 | -54.8% | 199,054 | +8.3% | 0.00% | -100.0% |
| Q1 2016 | $1,273,000 | -20.0% | 183,740 | +0.7% | 0.00% | 0.0% |
| Q4 2015 | $1,591,000 | +35.2% | 182,526 | +1.4% | 0.00% | 0.0% |
| Q3 2015 | $1,177,000 | -33.9% | 180,027 | +10.8% | 0.00% | 0.0% |
| Q2 2015 | $1,780,000 | -28.4% | 162,491 | +10.7% | 0.00% | 0.0% |
| Q1 2015 | $2,486,000 | +9.5% | 146,755 | +3.6% | 0.00% | 0.0% |
| Q4 2014 | $2,271,000 | +179.0% | 141,632 | +18.8% | 0.00% | 0.0% |
| Q3 2014 | $814,000 | +20.1% | 119,203 | +41.3% | 0.00% | – |
| Q2 2014 | $678,000 | -5.4% | 84,370 | +6.0% | 0.00% | – |
| Q1 2014 | $717,000 | +24.9% | 79,572 | +2.3% | 0.00% | – |
| Q4 2013 | $574,000 | +5.3% | 77,748 | +34.5% | 0.00% | – |
| Q3 2013 | $545,000 | -2.3% | 57,823 | +1.6% | 0.00% | – |
| Q2 2013 | $558,000 | – | 56,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|